|
業務類別
|
Biotechnology |
|
業務概覽
|
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors. |
| 公司地址
| 315 Montgomery Street, 10th Floor, San Francisco, CA, USA, 94104 |
| 電話號碼
| +1 415 919-4040 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.gtbiopharma.com |
| 員工數量
| 1 |
| Mr. Alan Louis Urban |
Chief Financial Officer, Principal Accounting Officer and Secretary |
美元 393.75K |
02/03/2026 |
| Mr. Michael Breen |
Executive Chairman of the Board and Chief Executive Officer |
美元 641.02K |
02/03/2026 |
|
|
| Ms. Hilary Kramer |
Director |
02/03/2026 |
| Mr. Michael Breen |
Executive Chairman of the Board and Chief Executive Officer |
02/03/2026 |
| Mr. David C. Mun-Gavin |
Independent Director |
02/03/2026 |
| Mr. Charles J. Casamento |
Independent Director |
02/03/2026 |
|
|
|
|
